Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Profarma Distribuidora De Produtos Farmaceuticos's average EBITDA Per Share Growth Rate was 36.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 12.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 20.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 13.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Profarma Distribuidora De Produtos Farmaceuticos was 50.50% per year. The lowest was -36.40% per year. And the median was -0.70% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Profarma Distribuidora De Produtos Farmaceuticos 3-Year EBITDA Growth Rate Related Terms
BSP:PFRM3 vs MCK, COR, CAH: 3-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profarma Distribuidora De Produtos Farmaceuticos 3-Year EBITDA Growth Rate vs Medical Distribution Industry
Profarma Distribuidora De Produtos Farmaceuticos 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 12.30% mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a 3-Year EBITDA Growth Rate of 12.30% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Profarma Distribuidora De Produtos Farmaceuticos and its competitors. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #40 out of 107 companies in the Medical Distribution industry, placing it in the top 37.4%.
Is Profarma Distribuidora De Produtos Farmaceuticos' 3-Year EBITDA Growth Rate too high?
Profarma Distribuidora De Produtos Farmaceuticos' current 3-Year EBITDA Growth Rate is 12.30%. The Medical Distribution industry median 3-Year EBITDA Growth Rate is 6.10. Profarma Distribuidora De Produtos Farmaceuticos' value of 12.30% is 101.6% above this industry median. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #40 out of 107 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' 3-Year EBITDA Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #40 out of 107 companies for 3-Year EBITDA Growth Rate. This puts Profarma Distribuidora De Produtos Farmaceuticos in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 6.10. Profarma Distribuidora De Produtos Farmaceuticos' value of 12.30% is 101.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Distribution company?
The median 3-Year EBITDA Growth Rate among Medical Distribution companies is 6.10, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profarma Distribuidora De Produtos Farmaceuticos's current 3-Year EBITDA Growth Rate of 12.30% is 101.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Profarma Distribuidora De Produtos Farmaceuticos and its competitors. For the Medical Distribution industry, the median 3-Year EBITDA Growth Rate is 6.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profarma Distribuidora De Produtos Farmaceuticos's current 3-Year EBITDA Growth Rate is 12.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Fairly Valued. The stock's GF Value™ is R$8.55, compared to a current price of R$7.87 — trading 8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 12.30% and 101.6% above the Medical Distribution industry median of 6.10. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current 3-Year EBITDA Growth Rate is 12.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued.
The current stock price of R$7.87 is trading 8% below its estimated GF Value™ of R$8.55.
GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Fairly Valued.
Key valuation signals for BSP:PFRM3:
3-Year EBITDA Growth Rate: 12.30%
GF Value™: R$8.55 vs. price of R$7.87 (8% below fair value)
Industry Position: 101.6% above the Medical Distribution median (#40 of 107)
No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
74GF Score
Get the complete analysis for BSP:PFRM3
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PFRM3 has been successfully added to your 
